Applied DNA Sciences Inc APDN:NASDAQ

Last Price$3.70NASDAQ Previous Close - Last Trade as of 4:00PM ET 8/12/22
NASDAQ 15-minute delayed Bid/Ask Quotes
Today's Change0(0.00%)
Bid (Size)$3.62 (1)
Ask (Size)$3.72 (11)
Day Low / HighN/A - N/A
Volume4.0 M
 

View Biotechnology IndustryPeer Comparison as of 08/12/2022

 

Applied DNA Sciences Inc ( NASDAQ )

Price: $3.70
Change: -0.82 (18.14%)
Volume: 4.0 M
4:00PM ET 8/12/2022
 
 

Orgenesis Inc ( NASDAQ )

Price: $1.80
Change: +0.14 (8.43%)
Volume: 26.3 K
3:58PM ET 8/12/2022
 
 

Chemomab Therapeutics Ltd ( NASDAQ )

Price: $4.00
Change: +0.27 (7.24%)
Volume: 84.5 K
4:00PM ET 8/12/2022
 
 

Vaccinex Inc ( NASDAQ )

Price: $1.10
Change: +0.02 (1.85%)
Volume: 65.5 K
3:59PM ET 8/12/2022
 
 

AVROBIO Inc ( NASDAQ )

Price: $1.07
Change: +0.03 (2.88%)
Volume: 240.1 K
4:00PM ET 8/12/2022
 

Read more news Recent News

-- Earnings Flash (APDN) APPLIED DNA SCIENCES Reports Q3 Revenue $4.3M
4:23PM ET 8/11/2022 MT Newswires

...

Applied DNA Sciences Gets Contract Extension to Provide COVID-19 Services; Shares Rise
12:07PM ET 8/09/2022 MT Newswires

Applied DNA Sciences (APDN) said Tuesday that the City University of New York has extended its health services contract for COVID-19 testing and vaccine...

Applied DNA Sciences Closes $12 Million Upsized Public Offering; Shares Sink
1:41PM ET 8/08/2022 MT Newswires

Applied DNA Sciences (APDN) said Monday that it closed a public offering of 3 million shares, together with series A warrants to purchase up to 3 million...

--HC Wainwright Adjusts Applied DNA Sciences' Price Target to $8 from $4, Keeps Buy Rating
12:18PM ET 8/08/2022 MT Newswires

(MT Newswires covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may...

View all Commentary and Analysis

Applied DNA Sciences (APDN) Reports Q3 Loss, Tops Revenue Estimates
5:55PM ET 8/11/2022 Zacks

Applied DNA Sciences (APDN) delivered earnings and revenue surprises of 8.33% and 19.33%,...

Applied DNA Sciences, Inc. (APDN) CEO James Hayward on Q2 2022 Results - Earnings Call Transcript
11:37PM ET 5/13/2022 Seeking Alpha

Applied DNA Sciences, Inc.'s (APDN) CEO James Hayward on Q1 2022 Results - Earnings Call Transcript
6:58PM ET 2/10/2022 Seeking Alpha

Flora Ready To Grow Like A Weed
2:43PM ET 1/03/2022 Seeking Alpha

Company Profile

Business DescriptionApplied DNA Sciences, Inc. engages in the developing and marketing DNA-based technology solutions utilizing LinearDNA, large-scale polymerase chain reaction (PCR) based manufacturing platform. Its proprietary platform produces large quantities of DNA for use in nucleic acid-based in vitro diagnostics and preclinical nucleic-acid based drug development and manufacturing markets (Biotherapeutic Contract Research and Manufacturing) and for supply chain security, anti-counterfeiting and anti-theft technology purposes. The company was founded in 1983 and is headquartered in Stony Brook, NY. View company web site for more details
Address50 Health Sciences Drive
Stony Brook, New York 11790
Phone+1.631.240.8800
Number of Employees59
Recent SEC Filing08/11/202210-Q
Chairman, President & Chief Executive OfficerJames A. Hayward
Chief Operating OfficerJudy Murrah
Chief Financial Officer & ControllerBeth M. Jantzen
Associate Director-ProductionFrank Cipriani

Company Highlights

Price Open$4.30
Previous Close$4.52
52 Week Range$0.62 - 7.35
Market Capitalization$44.3 M
Shares Outstanding12.0 M
SectorHealth Technology
IndustryBiotechnology
Next Earnings Announcement12/08/2022

Options Summary

Call Open Interest (1d)*
Put Open Interest (1d)*
Call Volume (1d)*
Put Volume (1d)*
Put Call Open Interest Ratio (1d)*
Put Call Volume Ratio (1d)*
* Data delayed by up to 15 minutes

View all fundamentalsFundamentals

Price / EarningsN/A
Earnings per Share-$1.88
Beta vs. S&P 500N/A
Revenue$3.9 M
Net Profit Margin-95.93%
Return on Equity-135.14%

Analyst Ratings as of 08/03/2022

Buy
2
Overweight
0
Hold
0
Underweight
0
Sell
0
Consensus RecommendationConsensus Icon
Powered by Factset